NCT01285596View on ClinicalTrials.gov

A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Healthy VolunteersPharmacokinetics of Mirabegron
Interventions
DRUG

Mirabegron

oral

Trial Locations (1)

75015

Paris

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01285596 - A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex | Biotech Hunter | Biotech Hunter